BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
Pfizer agreed to pay nearly $60 million to resolve allegations that its Biohaven Pharmaceuticals unit paid kickbacks to entice physicians ...
When caring for a plant indoors, the goal is to recreate the conditions it would find out in nature. You ...
In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.